GeoVax Observes 2019 World AIDS Day
02 déc. 2019 09h00 HE
|
GeoVax, Inc.
Developing Multiple Strategies Toward Ending the HIV/AIDS Epidemic ATLANTA, GA, Dec. 02, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- GeoVax Labs, Inc. (OTC: GOVX), a biotechnology company...
GeoVax Presents HIV Vaccine Study Data
24 juil. 2019 09h00 HE
|
GeoVax, Inc.
Presentation Made at the 10th International AIDS Society Conference on HIV Science ATLANTA, GA, July 24, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- GeoVax Labs, Inc. (OTCQB: GOVX), a...
GeoVax Provides Update on HIV Clinical Trials Program
28 nov. 2018 09h00 HE
|
GeoVax, Inc.
Innovative Combination Vaccine Advancing in Clinical Trials ATLANTA, GA, Nov. 28, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company...
GeoVax Announces Further Positive Results of its HIV Preventive Vaccine Program at International HIV Research Conference
24 oct. 2018 11h00 HE
|
GeoVax, Inc.
Booster Vaccination After ~7 Years Resulted in 600-fold Increase in Antibody Response ATLANTA, GA, Oct. 24, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- GeoVax Labs, Inc. (OTCQB: GOVX), a...
GeoVax Announces Publication of HIV Vaccines Review
22 oct. 2018 09h00 HE
|
GeoVax, Inc.
Comprehensive Review Published in the Peer-Reviewed Journal, Clinical Pharmacology and Therapeutics ATLANTA, GA, Oct. 22, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – GeoVax Labs, Inc. (OTCQB:...
GeoVax Observes National Latinx AIDS Awareness Day
15 oct. 2018 09h00 HE
|
GeoVax, Inc.
ATLANTA, GA, Oct. 15, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, today is observing National Latinx AIDS...